Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Canadian Sec - Delayed Quote CAD

Quantum BioPharma Ltd. (QNTM.CN)

9.85
+0.35
+(3.68%)
At close: April 25 at 2:16:48 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Mr. Zeeshan Saeed Founder, CEO, President & Executive Co-Chairman 303.02k -- 1970
Mr. Anthony John Durkacz Founder & Executive Co-Chairman 303.02k -- 1976
Mr. Donal Carroll CPA Chief Financial Officer 303.02k -- 1977
Mr. Nathan Coyle CPA Controller 130.23k -- 1981
Dr. Lakshmi P. Kotra BPHARM, Ph.D. CEO of Lucid & Director -- -- 1971
Dr. Andrzej Chruscinski M.D., Ph.D. Vice President of Clinical & Scientific Affairs 246.99k -- --
Dr. Ashwini Joshi Director of Pharmaceutical Development 123.9k -- --
Mr. Jason D. Sawyer Head of Finance & Mergers and Acquisitions -- -- --
Ms. Maryann Adesso Corporate Secretary -- -- --
Randell Mack President of FSD BioSciences -- -- --

Quantum BioPharma Ltd.

55 University Ave.
Suite 1003
Toronto, ON M5J 2H7
Canada
833-571-1811 https://www.quantumbiopharma.com
Sector: 
Healthcare

Description

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company in the United States. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company also offers unbuzzd, a dietary supplement for alcohol recovery and clinical-stage healthcare solutions for emergency settings. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., was founded in 1998 and is headquartered in Toronto, Canada.

Corporate Governance

Quantum BioPharma Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 8:00 PM UTC - May 16, 2025 at 8:00 PM UTC

Quantum BioPharma Ltd. Earnings Date

Recent Events

Related Tickers

AGFAF Digicann Ventures Inc.
0.0155
0.00%
 
DCNN.CN Digicann Ventures Inc.
0.0200
0.00%
 
AUSA.CN Australis Capital Inc.
0.0250
0.00%
 
VM.V Voyageur Pharmaceuticals Ltd.
0.1750
0.00%
 
TRUFF Red Light Holland Corp.
0.0240
0.00%
 
ANIK Anika Therapeutics, Inc.
14.43
+0.38%
 
OILS.CN Nextleaf Solutions Ltd.
0.0550
+10.00%
 
KGKG Kona Gold Beverage, Inc.
0.0002
0.00%
 
CTOR Citius Oncology, Inc.
0.7290
+13.73%
 
CVSI CV Sciences, Inc.
0.0300
+5.26%